Abstract

Background: The exclusion of axillary lymph node clearance (ALNC) in patients with breast carcinoma when sentinel lymph node biopsy (SLNB) comes back negative has reduced arm morbidity and lymphedema significantly. The rate of axillary recurrence is substantially lower than expected in the early follow-up reports with a median false-negative rate of 6.7 per cent for SNB. Axillary recurrences may develop late therefore, long-term follow up reports are needed.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call